Artal Group as of Dec. 31, 2021
Portfolio Holdings for Artal Group
Artal Group holds 149 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Lexicon Pharmaceuticals Com New (LXRX) | 7.6 | $280M | 71M | 3.94 | |
| Ww Intl | 6.5 | $239M | 15M | 16.13 | |
| Mirati Therapeutics | 5.6 | $205M | 1.4M | 146.69 | |
| Beigene Sponsored Adr (ONC) | 5.0 | $183M | 675k | 270.93 | |
| Argenx Se Sponsored Adr (ARGX) | 4.8 | $175M | 500k | 350.19 | |
| Spdr Ser Tr S&p Biotech Call Option (XBI) | 3.0 | $112M | 1.0M | 111.96 | |
| Alnylam Pharmaceuticals (ALNY) | 3.0 | $110M | 650k | 169.58 | |
| Seer Com Cl A (SEER) | 2.9 | $108M | 4.8M | 22.81 | |
| Fate Therapeutics (FATE) | 2.9 | $105M | 1.8M | 58.51 | |
| Seagen | 2.1 | $77M | 500k | 154.60 | |
| Morphic Hldg (MORF) | 2.0 | $75M | 1.6M | 47.38 | |
| Amicus Therapeutics (FOLD) | 1.9 | $69M | 6.0M | 11.55 | |
| Bellus Health Com New | 1.9 | $68M | 8.5M | 8.05 | |
| Kymera Therapeutics (KYMR) | 1.7 | $64M | 1.0M | 63.49 | |
| Bristol Myers Squibb Call Option (BMY) | 1.7 | $62M | 1.0M | 62.35 | |
| Scholar Rock Hldg Corp (SRRK) | 1.7 | $61M | 2.5M | 24.84 | |
| Citigroup Com New Call Option (C) | 1.6 | $60M | 1.0M | 60.39 | |
| Sage Therapeutics (SAGE) | 1.4 | $53M | 1.3M | 42.54 | |
| Springworks Therapeutics (SWTX) | 1.4 | $53M | 850k | 61.98 | |
| Erasca (ERAS) | 1.3 | $49M | 3.2M | 15.58 | |
| Krystal Biotech (KRYS) | 1.3 | $49M | 700k | 69.95 | |
| Cerevel Therapeutics Hldng I (CERE) | 1.3 | $49M | 1.5M | 32.42 | |
| Cytokinetics Com New (CYTK) | 1.2 | $46M | 1.0M | 45.58 | |
| Igm Biosciences (IGMS) | 1.2 | $44M | 1.5M | 29.33 | |
| Protagonist Therapeutics (PTGX) | 1.2 | $43M | 1.3M | 34.20 | |
| I Mab Sponsored Ads (IMAB) | 1.1 | $40M | 850k | 47.39 | |
| Foghorn Therapeutics (FHTX) | 1.1 | $39M | 1.7M | 22.87 | |
| Rubius Therapeutics | 1.0 | $36M | 3.7M | 9.68 | |
| Intellia Therapeutics (NTLA) | 0.9 | $33M | 275k | 118.24 | |
| Talaris Therapeutics | 0.9 | $32M | 2.1M | 15.29 | |
| Allovir (ALVR) | 0.8 | $30M | 2.3M | 12.94 | |
| Evotec Sponsored Ads (EVO) | 0.7 | $27M | 1.1M | 23.75 | |
| Eqrx | 0.7 | $27M | 4.0M | 6.82 | |
| Denali Therapeutics (DNLI) | 0.7 | $27M | 600k | 44.60 | |
| Gossamer Bio (GOSS) | 0.7 | $27M | 2.4M | 11.31 | |
| Omega Therapeutics Common Stock (OMGAQ) | 0.7 | $26M | 2.3M | 11.33 | |
| Iteos Therapeutics | 0.7 | $25M | 544k | 46.56 | |
| Replimune Group (REPL) | 0.7 | $24M | 900k | 27.10 | |
| Schrodinger (SDGR) | 0.7 | $24M | 700k | 34.83 | |
| Atara Biotherapeutics | 0.6 | $24M | 1.5M | 15.76 | |
| Praxis Precision Medicines I | 0.6 | $24M | 1.2M | 19.70 | |
| Relay Therapeutics (RLAY) | 0.6 | $23M | 750k | 30.71 | |
| Aurinia Pharmaceuticals (AUPH) | 0.6 | $23M | 1.0M | 22.87 | |
| Vertex Pharmaceuticals Incorporated Call Option (VRTX) | 0.6 | $22M | 100k | 219.60 | |
| Kronos Bio | 0.6 | $21M | 1.5M | 13.59 | |
| Agenus Com New | 0.6 | $21M | 6.5M | 3.22 | |
| Generation Bio | 0.5 | $20M | 2.8M | 7.08 | |
| Ambrx Biopharma Sponsored Ads | 0.5 | $19M | 2.2M | 9.03 | |
| Ikena Oncology (IKNA) | 0.5 | $19M | 1.5M | 12.54 | |
| Novagold Res Com New (NG) | 0.5 | $18M | 2.6M | 6.86 | |
| Aptinyx | 0.4 | $16M | 6.1M | 2.67 | |
| Intel Corporation Call Option (INTC) | 0.4 | $16M | 300k | 51.50 | |
| Tg Therapeutics (TGTX) | 0.4 | $15M | 800k | 19.00 | |
| Repare Therapeutics Ord (RPTX) | 0.4 | $15M | 700k | 21.09 | |
| Verve Therapeutics (VERV) | 0.4 | $15M | 400k | 36.87 | |
| Kura Oncology (KURA) | 0.4 | $15M | 1.1M | 14.00 | |
| Sqz Biotech (SQZB) | 0.4 | $14M | 1.6M | 8.93 | |
| Forma Therapeutics Hldgs SHS | 0.4 | $14M | 1.0M | 14.22 | |
| Albireo Pharma | 0.4 | $14M | 600k | 23.29 | |
| Selecta Biosciences | 0.4 | $13M | 4.0M | 3.26 | |
| Leap Therapeutics | 0.4 | $13M | 4.0M | 3.24 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.3 | $12M | 1.0M | 11.65 | |
| Oatly Group Ab Sponsored Ads | 0.3 | $12M | 1.5M | 7.96 | |
| Turning Point Therapeutics I | 0.3 | $12M | 250k | 47.70 | |
| Marinus Pharmaceuticals Com New | 0.3 | $12M | 1.0M | 11.88 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.3 | $11M | 2.3M | 5.01 | |
| Exscientia Ads (EXAI) | 0.3 | $11M | 550k | 19.76 | |
| Alx Oncology Hldgs (ALXO) | 0.3 | $11M | 500k | 21.49 | |
| Syros Pharmaceuticals | 0.3 | $9.8M | 3.0M | 3.26 | |
| Gritstone Oncology Ord (GRTSQ) | 0.3 | $9.6M | 750k | 12.86 | |
| Black Diamond Therapeutics (BDTX) | 0.2 | $8.8M | 1.6M | 5.33 | |
| Graphite Bio | 0.2 | $8.7M | 700k | 12.43 | |
| Design Therapeutics (DSGN) | 0.2 | $8.6M | 400k | 21.41 | |
| Alpine Immune Sciences | 0.2 | $8.2M | 593k | 13.85 | |
| Nanobiotix Sa Sponsored Ads (NBTX) | 0.2 | $8.1M | 1.0M | 8.10 | |
| Adagene Ads (ADAG) | 0.2 | $8.1M | 1.0M | 8.07 | |
| Ovid Therapeutics (OVID) | 0.2 | $8.0M | 2.5M | 3.21 | |
| Spero Therapeutics (SPRO) | 0.2 | $8.0M | 500k | 16.01 | |
| Instil Bio | 0.2 | $7.7M | 450k | 17.11 | |
| Harpoon Therapeutics | 0.2 | $7.6M | 1.0M | 7.55 | |
| Mersana Therapeutics | 0.2 | $7.5M | 1.2M | 6.22 | |
| Zymeworks | 0.2 | $7.4M | 450k | 16.39 | |
| Omega Alpha Spac Cl A | 0.2 | $7.3M | 750k | 9.77 | |
| Xilio Therapeutics (XLO) | 0.2 | $7.2M | 450k | 16.00 | |
| Immunocore Hldgs Ads (IMCR) | 0.2 | $6.8M | 200k | 34.24 | |
| Immunic (IMUX) | 0.2 | $6.7M | 700k | 9.57 | |
| Y Mabs Therapeutics | 0.2 | $6.5M | 400k | 16.21 | |
| Vor Biopharma (VOR) | 0.2 | $6.4M | 550k | 11.62 | |
| Dyne Therapeutics (DYN) | 0.2 | $6.2M | 525k | 11.89 | |
| Sana Biotechnology (SANA) | 0.2 | $6.2M | 400k | 15.48 | |
| Curis Com New | 0.2 | $6.2M | 1.3M | 4.76 | |
| Caribou Biosciences (CRBU) | 0.2 | $6.1M | 405k | 15.09 | |
| Evelo Biosciences | 0.2 | $6.1M | 1.0M | 6.07 | |
| Stoke Therapeutics (STOK) | 0.2 | $6.0M | 250k | 23.99 | |
| Avidity Biosciences Ord (RNA) | 0.2 | $5.9M | 250k | 23.77 | |
| Oric Pharmaceuticals (ORIC) | 0.2 | $5.9M | 400k | 14.70 | |
| Neximmune | 0.2 | $5.5M | 1.2M | 4.61 | |
| Lyell Immunopharma | 0.1 | $5.4M | 700k | 7.74 | |
| Adverum Biotechnologies | 0.1 | $5.3M | 3.0M | 1.76 | |
| Solid Biosciences | 0.1 | $5.3M | 3.0M | 1.75 | |
| Mirion Technologies Com Cl A (MIR) | 0.1 | $5.2M | 500k | 10.47 | |
| Aeglea Biotherapeutics | 0.1 | $5.0M | 1.0M | 4.75 | |
| Ac Immune Sa SHS (ACIU) | 0.1 | $5.0M | 1.0M | 4.95 | |
| Dynamics Special Purpose Cor Class A Com | 0.1 | $4.9M | 500k | 9.86 | |
| Cyclerion Therapeutics | 0.1 | $4.8M | 2.8M | 1.72 | |
| GDS HLDGS Sponsored Ads (GDS) | 0.1 | $4.7M | 100k | 47.16 | |
| Iqiyi Sponsored Ads (IQ) | 0.1 | $4.6M | 1.0M | 4.56 | |
| Cardiff Oncology (CRDF) | 0.1 | $4.5M | 750k | 6.01 | |
| 23andme Holding Class A Com | 0.1 | $4.4M | 661k | 6.66 | |
| Bridgebio Pharma (BBIO) | 0.1 | $4.2M | 250k | 16.68 | |
| Contrafect Corp Com New | 0.1 | $3.9M | 1.5M | 2.63 | |
| Phathom Pharmaceuticals (PHAT) | 0.1 | $3.9M | 200k | 19.67 | |
| Cullinan Oncology (CGEM) | 0.1 | $3.9M | 250k | 15.43 | |
| Portage Fintech Acquisitn Class A Ord Shs | 0.1 | $3.8M | 380k | 9.95 | |
| Applied Therapeutics (APLT) | 0.1 | $3.6M | 400k | 8.95 | |
| Tcr2 Therapeutics Inc cs | 0.1 | $3.5M | 750k | 4.66 | |
| Recursion Pharmaceuticals In Cl A (RXRX) | 0.1 | $3.4M | 200k | 17.13 | |
| 111 Ads | 0.1 | $3.4M | 966k | 3.50 | |
| Immutep Sponsored Ads (IMMP) | 0.1 | $3.3M | 1.0M | 3.28 | |
| Wave Life Sciences SHS (WVE) | 0.1 | $3.1M | 1.0M | 3.14 | |
| Fusion Pharmaceuticals | 0.1 | $3.1M | 750k | 4.17 | |
| Chinook Therapeutics | 0.1 | $2.9M | 181k | 16.31 | |
| Aravive | 0.1 | $2.9M | 1.3M | 2.19 | |
| Mei Pharma Com New | 0.1 | $2.7M | 1.0M | 2.67 | |
| Olema Pharmaceuticals (OLMA) | 0.1 | $2.4M | 261k | 9.36 | |
| Mereo Biopharma Group Ads (MREO) | 0.1 | $2.4M | 1.5M | 1.60 | |
| Orchard Therapeutics Ads | 0.1 | $2.4M | 1.8M | 1.32 | |
| Codiak Biosciences | 0.1 | $2.2M | 200k | 11.14 | |
| Kinnate Biopharma | 0.1 | $2.2M | 125k | 17.72 | |
| Hippo Hldgs Common Stock | 0.0 | $1.7M | 600k | 2.83 | |
| Amryt Pharma Sponsored Ads | 0.0 | $1.6M | 151k | 10.80 | |
| Axcella Health Inc equity | 0.0 | $1.5M | 713k | 2.09 | |
| Hookipa Pharma Inc equity | 0.0 | $1.4M | 600k | 2.33 | |
| Mink Therapeutics | 0.0 | $1.3M | 290k | 4.46 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.0 | $1.3M | 111k | 11.66 | |
| Corvus Pharmaceuticals (CRVS) | 0.0 | $1.2M | 500k | 2.41 | |
| Kaleido Biosciences Ord (KLDO) | 0.0 | $1.2M | 501k | 2.39 | |
| Lava Therapeutics Nv SHS (LVTX) | 0.0 | $1.1M | 200k | 5.50 | |
| Deciphera Pharmaceuticals | 0.0 | $977k | 100k | 9.77 | |
| Rigel Pharmaceuticals Com New | 0.0 | $851k | 321k | 2.65 | |
| Sigilon Therapeutics | 0.0 | $762k | 276k | 2.76 | |
| Marrone Bio Innovations | 0.0 | $755k | 1.0M | 0.72 | |
| Rivian Automotive Com Cl A (RIVN) | 0.0 | $726k | 7.0k | 103.71 | |
| Dlocal Class A Com (DLO) | 0.0 | $714k | 20k | 35.70 | |
| Yumanity Therapeutics | 0.0 | $643k | 217k | 2.96 | |
| Metacrine Ord | 0.0 | $624k | 925k | 0.67 | |
| Surface Oncology | 0.0 | $478k | 100k | 4.78 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.0 | $285k | 225k | 1.27 | |
| Astria Therapeutics (ATXS) | 0.0 | $180k | 33k | 5.40 |